US Patent

US10918694 — Topical cyclosporine-containing formulations and uses thereof

Formulation · Assigned to Sun Pharma Global FZE · Expires 2037-02-28 · 11y remaining

Vulnerability score 42/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects topical ophthalmic formulations containing cyclosporine in specific concentrations, along with methods for making and using these formulations.

USPTO Abstract

Provided herein are formulations for topical ophthalmic formulations containing 0.087-0.093 wt % of cyclosporine, and methods of making and using such formulations. In some aspects and embodiments the formulations may include a polyoxyl lipid or fatty acid, and/or a polyalkoxylated alcohol and may include nanomicelles. Also included herein are methods of treating or preventing diseases or conditions, such as ocular diseases or conditions.

Drugs covered by this patent

Patent Metadata

Patent number
US10918694
Jurisdiction
US
Classification
Formulation
Expires
2037-02-28
Drug substance claim
No
Drug product claim
Yes
Assignee
Sun Pharma Global FZE
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.